RedCap testing refers to the systematic validation, verification, and performance assessment of REDCap (Research Electronic Data Capture) implementations used for clinical research, academic studies, and health‑care data management. As institutions accelerate digital trial adoption, the RedCap Testing market size has reached roughly USD 130 million in 2025, with a market forecast projecting a compound annual growth rate (CAGR) of 9.2% through 2033. The growth outlook is driven by expanding clinical‑trial pipelines, stricter data‑integrity regulations, and rising demand for cloud‑based, interoperable research platforms. Macro‑level forces such as increased federal funding for translational research, heightened cybersecurity mandates, and the shift toward decentralized trials underpin this expansion.